GlassScriptPhysician profile
Ashley Baird Richards
NPI 1881107167
$1,778.39
in general payments reported to CMS, 2019-2025
16 companies · $14.80 in 2025
The $14.80 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $984 · 2022: $343 · 2023: $279 · 2024: $159 · 2025: $14.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405 · Education: $46.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.18 |
| Education | $46.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $365.49 | 2021-2024 | Trintellix |
| Axsome Therapeutics, INC. | $287.04 | 2022-2024 | Auvelity |
| Abbvie INC. | $272.70 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $233.76 | 2021-2022 | |
| Lundbeck LLC | $101.12 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $89.38 | 2021 | |
| Bausch Health US, LLC | $86.74 | 2021-2023 | Aplenzin |
| Adlon Therapeutics L.P. | $75.93 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $71.73 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.91 | 2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $35.00 | 2021 | |
| Eisai INC. | $30.42 | 2021 | |
| Merck Sharp & Dohme LLC | $28.20 | 2021 | |
| Orexo US, INC. | $18.71 | 2021 | |
| Avanir Pharmaceuticals, INC. | $17.92 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.